name	nAnno	nOverlap	fc	zscore	pvalue	adjp	or	CIl	CIu
R-HSA-8953854	Metabolism of RNA	646	438	1.76	15.8	7e-55	8.5e-52	3.67	3.09	4.38
R-HSA-72766	Translation	258	206	2.08	13.8	4.7e-43	2.8e-40	6.64	4.86	9.2
R-HSA-72163	mRNA Splicing - Major Pathway	183	149	2.12	12.1	3.4e-33	1.4e-30	7.25	4.95	10.9
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	243	183	1.96	11.9	3.4e-32	1e-29	5.07	3.76	6.93
R-HSA-72172	mRNA Splicing	191	152	2.07	11.8	1.1e-31	2.7e-29	6.45	4.5	9.44
R-HSA-392499	Metabolism of proteins	1907	958	1.31	11.7	2.2e-31	4.5e-29	1.82	1.64	2.01
R-HSA-5663205	Infectious disease	326	226	1.8	11.6	1.9e-30	3.4e-28	3.78	2.96	4.85
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	165	124	1.95	9.76	5e-22	7.6e-20	4.96	3.45	7.27
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	118	96	2.11	9.63	9.7e-22	1.3e-19	7.13	4.44	11.9
R-HSA-927802	Nonsense-Mediated Decay (NMD)	115	93	2.1	9.4	9.5e-21	1e-18	6.9	4.29	11.6
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	115	93	2.1	9.4	9.5e-21	1e-18	6.9	4.29	11.6
R-HSA-199991	Membrane Trafficking	599	339	1.47	9.4	1.6e-20	1.6e-18	2.19	1.85	2.6
R-HSA-168273	Influenza Viral RNA Transcription and Replication	133	103	2.01	9.3	3.4e-20	3.2e-18	5.61	3.7	8.76
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	310	198	1.66	9.34	3.8e-20	3.3e-18	2.93	2.3	3.74
R-HSA-168255	Influenza Life Cycle	143	108	1.96	9.17	1.3e-19	1e-17	5.05	3.41	7.63
R-HSA-168254	Influenza Infection	154	114	1.92	9.14	1.9e-19	1.4e-17	4.67	3.22	6.88
R-HSA-611105	Respiratory electron transport	95	79	2.16	8.99	3e-19	2.2e-17	8.04	4.65	14.8
R-HSA-72613	Eukaryotic Translation Initiation	119	92	2.01	8.76	4.4e-18	2.8e-16	5.56	3.58	8.9
R-HSA-72737	Cap-dependent Translation Initiation	119	92	2.01	8.76	4.4e-18	2.8e-16	5.56	3.58	8.9
R-HSA-1640170	Cell Cycle	607	334	1.43	8.65	1.2e-17	7e-16	2.05	1.73	2.42
R-HSA-5653656	Vesicle-mediated transport	631	345	1.42	8.64	1.2e-17	7e-16	2.02	1.71	2.39
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	111	86	2.01	8.49	4.3e-17	2.4e-15	5.6	3.55	9.15
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	112	86	2	8.38	1.2e-16	6.1e-15	5.39	3.43	8.72
R-HSA-3700989	Transcriptional Regulation by TP53	365	217	1.55	8.39	1.2e-16	6.2e-15	2.43	1.95	3.02
R-HSA-5617833	Cilium Assembly	201	134	1.73	8.3	3e-16	1.4e-14	3.28	2.42	4.48
R-HSA-72689	Formation of a pool of free 40S subunits	101	79	2.03	8.25	3.1e-16	1.4e-14	5.84	3.6	9.86
R-HSA-5419276	Mitochondrial translation termination	86	70	2.12	8.22	3.2e-16	1.5e-14	7.11	4.08	13.1
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	93	74	2.07	8.18	4.9e-16	2.1e-14	6.33	3.78	11.1
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	95	75	2.05	8.15	6.9e-16	2.9e-14	6.1	3.68	10.6
R-HSA-8868773	rRNA processing in the nucleus and cytosol	191	128	1.74	8.19	7.4e-16	3e-14	3.33	2.43	4.59
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	182	123	1.76	8.15	1e-15	3.9e-14	3.41	2.47	4.75
R-HSA-5368287	Mitochondrial translation	87	70	2.09	8.08	1e-15	3.9e-14	6.69	3.89	12.1
R-HSA-192823	Viral mRNA Translation	89	71	2.07	8.04	1.5e-15	5.5e-14	6.41	3.77	11.4
R-HSA-983169	Class I MHC mediated antigen processing & presentation	365	213	1.52	7.95	4e-15	1.4e-13	2.31	1.86	2.88
R-HSA-69275	G2/M Transition	195	128	1.71	7.88	8.6e-15	3e-13	3.13	2.3	4.28
R-HSA-5389840	Mitochondrial translation elongation	84	67	2.07	7.81	9.7e-15	3.3e-13	6.4	3.71	11.6
R-HSA-162906	HIV Infection	184	122	1.72	7.83	1.2e-14	4e-13	3.22	2.34	4.45
R-HSA-1852241	Organelle biogenesis and maintenance	269	165	1.59	7.81	1.3e-14	4.1e-13	2.61	2.02	3.38
R-HSA-597592	Post-translational protein modification	1353	648	1.24	7.66	2.1e-14	6.4e-13	1.57	1.39	1.76
R-HSA-453274	Mitotic G2-G2/M phases	197	128	1.69	7.72	2.8e-14	8.4e-13	3.03	2.24	4.14
R-HSA-72312	rRNA processing	201	130	1.68	7.71	2.9e-14	8.5e-13	3	2.22	4.07
R-HSA-69278	Cell Cycle, Mitotic	531	288	1.41	7.67	2.9e-14	8.5e-13	1.97	1.64	2.36
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	67	56	2.17	7.61	3.4e-14	9.3e-13	8.24	4.27	17.5
R-HSA-73856	RNA Polymerase II Transcription Termination	67	56	2.17	7.61	3.4e-14	9.3e-13	8.24	4.27	17.5
R-HSA-1643685	Disease	984	488	1.29	7.55	5.4e-14	1.5e-12	1.66	1.45	1.89
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	74	60	2.11	7.56	6.2e-14	1.6e-12	6.95	3.83	13.5
R-HSA-6807070	PTEN Regulation	140	97	1.8	7.55	1e-13	2.6e-12	3.67	2.53	5.41
R-HSA-8951664	Neddylation	235	146	1.61	7.54	1e-13	2.6e-12	2.69	2.04	3.55
R-HSA-8953897	Cellular responses to external stimuli	493	268	1.41	7.44	1.7e-13	4.2e-12	1.97	1.64	2.38
R-HSA-72187	mRNA 3'-end processing	58	49	2.2	7.22	6.1e-13	1.5e-11	8.8	4.27	20.4
R-HSA-162909	Host Interactions of HIV factors	128	88	1.79	7.09	2.9e-12	6.9e-11	3.58	2.43	5.35
R-HSA-5696398	Nucleotide Excision Repair	111	78	1.83	6.92	8.9e-12	2.1e-10	3.84	2.52	5.97
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	54	45	2.17	6.79	1.4e-11	3.3e-10	8.08	3.89	18.8
R-HSA-5658442	Regulation of RAS by GAPs	68	53	2.03	6.71	3.2e-11	7.3e-10	5.72	3.17	10.9
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	79	59	1.94	6.64	5.7e-11	1.2e-09	4.78	2.83	8.39
R-HSA-195253	Degradation of beta-catenin by the destruction complex	81	60	1.93	6.61	6.9e-11	1.5e-09	4.63	2.77	8.02
R-HSA-4641258	Degradation of DVL	57	46	2.1	6.57	7.5e-11	1.6e-09	6.76	3.44	14.5
R-HSA-68886	M Phase	391	212	1.41	6.53	8.9e-11	1.9e-09	1.95	1.58	2.4
R-HSA-199977	ER to Golgi Anterograde Transport	155	99	1.66	6.55	1e-10	2.1e-09	2.88	2.05	4.08
R-HSA-8939902	Regulation of RUNX2 expression and activity	59	47	2.07	6.52	1.1e-10	2.2e-09	6.33	3.3	13.1
R-HSA-73894	DNA Repair	315	176	1.45	6.45	1.6e-10	3.2e-09	2.07	1.64	2.62
R-HSA-69620	Cell Cycle Checkpoints	292	165	1.47	6.43	1.9e-10	3.6e-09	2.13	1.67	2.71
R-HSA-674695	RNA Polymerase II Pre-transcription Events	84	61	1.89	6.46	1.9e-10	3.7e-09	4.29	2.61	7.28
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	63	49	2.02	6.43	2.1e-10	3.9e-09	5.66	3.07	11.1
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	97	68	1.82	6.43	2.3e-10	4.3e-09	3.8	2.42	6.1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	60	47	2.04	6.37	3.2e-10	5.8e-09	5.84	3.1	11.8
R-HSA-4641257	Degradation of AXIN	55	44	2.08	6.35	3.4e-10	6e-09	6.46	3.28	13.9
R-HSA-6799198	Complex I biogenesis	55	44	2.08	6.35	3.4e-10	6e-09	6.46	3.28	13.9
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	67	51	1.98	6.36	3.6e-10	6.3e-09	5.15	2.89	9.69
R-HSA-1257604	PIP3 activates AKT signaling	254	146	1.49	6.31	4.1e-10	7.2e-09	2.21	1.7	2.87
R-HSA-5663202	Diseases of signal transduction	359	195	1.41	6.29	4.3e-10	7.3e-09	1.95	1.57	2.42
R-HSA-8856828	Clathrin-mediated endocytosis	140	90	1.67	6.32	4.4e-10	7.5e-09	2.92	2.04	4.23
R-HSA-2262752	Cellular responses to stress	425	225	1.38	6.27	4.5e-10	7.5e-09	1.85	1.51	2.26
R-HSA-5610780	Degradation of GLI1 by the proteasome	57	45	2.05	6.3	4.7e-10	7.7e-09	6.06	3.15	12.6
R-HSA-69541	Stabilization of p53	57	45	2.05	6.3	4.7e-10	7.7e-09	6.06	3.15	12.6
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	80	58	1.88	6.28	6e-10	9.5e-09	4.27	2.57	7.33
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	59	46	2.03	6.25	6.5e-10	1e-08	5.71	3.03	11.5
R-HSA-180585	Vif-mediated degradation of APOBEC3G	54	43	2.07	6.23	7.1e-10	1.1e-08	6.31	3.2	13.6
R-HSA-2467813	Separation of Sister Chromatids	191	115	1.57	6.23	7.1e-10	1.1e-08	2.46	1.82	3.35
R-HSA-5678895	Defective CFTR causes cystic fibrosis	61	47	2	6.21	8.6e-10	1.3e-08	5.42	2.93	10.7
R-HSA-5628897	TP53 Regulates Metabolic Genes	86	61	1.84	6.21	9.1e-10	1.4e-08	3.95	2.44	6.58
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	51	41	2.09	6.17	1e-09	1.5e-08	6.62	3.25	14.8
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	51	41	2.09	6.17	1e-09	1.5e-08	6.62	3.25	14.8
R-HSA-446203	Asparagine N-linked glycosylation	299	166	1.44	6.15	1e-09	1.5e-08	2.04	1.61	2.59
R-HSA-69242	S Phase	138	88	1.66	6.15	1.3e-09	1.8e-08	2.86	1.99	4.14
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	65	49	1.96	6.14	1.4e-09	2e-08	4.95	2.76	9.34
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	83	59	1.85	6.13	1.5e-09	2.1e-08	3.98	2.43	6.7
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	87	61	1.82	6.09	1.9e-09	2.6e-08	3.8	2.36	6.27
R-HSA-8941858	Regulation of RUNX3 expression and activity	55	43	2.03	6.07	2e-09	2.8e-08	5.78	2.99	12.1
R-HSA-73762	RNA Polymerase I Transcription Initiation	45	37	2.14	6.05	2.1e-09	2.8e-08	7.46	3.41	18.6
R-HSA-68882	Mitotic Anaphase	202	119	1.53	6.03	2.3e-09	3.1e-08	2.33	1.74	3.14
R-HSA-180534	Vpu mediated degradation of CD4	52	41	2.05	6	3.1e-09	3.8e-08	6.01	3.03	13
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	52	41	2.05	6	3.1e-09	3.8e-08	6.01	3.03	13
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	52	41	2.05	6	3.1e-09	3.8e-08	6.01	3.03	13
R-HSA-69610	p53-Independent DNA Damage Response	52	41	2.05	6	3.1e-09	3.8e-08	6.01	3.03	13
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	52	41	2.05	6	3.1e-09	3.8e-08	6.01	3.03	13
R-HSA-72165	mRNA Splicing - Minor Pathway	52	41	2.05	6	3.1e-09	3.8e-08	6.01	3.03	13
R-HSA-69206	G1/S Transition	124	80	1.68	6	3.2e-09	4e-08	2.95	2.01	4.37
R-HSA-6782135	Dual incision in TC-NER	66	49	1.93	5.99	3.4e-09	4.2e-08	4.66	2.63	8.64
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	59	45	1.98	5.99	3.5e-09	4.2e-08	5.19	2.79	10.2
R-HSA-2555396	Mitotic Metaphase and Anaphase	203	119	1.52	5.96	3.5e-09	4.2e-08	2.31	1.72	3.1
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	54	42	2.02	5.95	4.2e-09	4.9e-08	5.65	2.91	11.8
R-HSA-379716	Cytosolic tRNA aminoacylation	24	23	2.49	5.78	4.2e-09	4.9e-08	37	6	1510
R-HSA-112382	Formation of RNA Pol II elongation complex 	61	46	1.96	5.95	4.5e-09	5.2e-08	4.95	2.71	9.56
R-HSA-75955	RNA Polymerase II Transcription Elongation	61	46	1.96	5.95	4.5e-09	5.2e-08	4.95	2.71	9.56
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	56	43	2	5.91	5.5e-09	6.2e-08	5.34	2.81	10.8
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	56	43	2	5.91	5.5e-09	6.2e-08	5.34	2.81	10.8
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	72	52	1.88	5.91	5.8e-09	6.5e-08	4.2	2.46	7.44
R-HSA-8854518	AURKA Activation by TPX2	72	52	1.88	5.91	5.8e-09	6.5e-08	4.2	2.46	7.44
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	51	40	2.04	5.88	6.4e-09	7e-08	5.87	2.95	12.7
R-HSA-380259	Loss of Nlp from mitotic centrosomes	69	50	1.88	5.82	9.5e-09	1e-07	4.25	2.46	7.65
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	69	50	1.88	5.82	9.5e-09	1e-07	4.25	2.46	7.65
R-HSA-8948751	Regulation of PTEN stability and activity	69	50	1.88	5.82	9.5e-09	1e-07	4.25	2.46	7.65
R-HSA-4608870	Asymmetric localization of PCP proteins	62	46	1.93	5.8	1.1e-08	1.1e-07	4.64	2.57	8.79
R-HSA-379724	tRNA Aminoacylation	35	30	2.23	5.75	1.1e-08	1.1e-07	9.66	3.71	31.9
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	55	42	1.99	5.79	1.1e-08	1.2e-07	5.21	2.74	10.6
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	86	59	1.78	5.77	1.3e-08	1.3e-07	3.53	2.2	5.81
R-HSA-165159	mTOR signalling	40	33	2.14	5.73	1.4e-08	1.4e-07	7.6	3.3	20.4
R-HSA-1169091	Activation of NF-kappaB in B cells	66	48	1.89	5.74	1.5e-08	1.6e-07	4.31	2.45	7.88
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	66	48	1.89	5.74	1.5e-08	1.6e-07	4.31	2.45	7.88
R-HSA-453279	Mitotic G1-G1/S phases	143	88	1.6	5.71	1.6e-08	1.6e-07	2.6	1.83	3.71
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	59	44	1.94	5.72	1.7e-08	1.7e-07	4.73	2.58	9.17
R-HSA-68867	Assembly of the pre-replicative complex	68	49	1.87	5.71	1.8e-08	1.8e-07	4.16	2.4	7.5
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	72	51	1.84	5.66	2.4e-08	2.3e-07	3.92	2.31	6.88
R-HSA-68874	M/G1 Transition	85	58	1.77	5.66	2.3e-08	2.3e-07	3.47	2.16	5.71
R-HSA-69002	DNA Replication Pre-Initiation	85	58	1.77	5.66	2.3e-08	2.3e-07	3.47	2.16	5.71
R-HSA-69306	DNA Replication	108	70	1.68	5.66	2.3e-08	2.3e-07	2.98	1.98	4.56
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	74	52	1.83	5.64	2.7e-08	2.5e-07	3.82	2.27	6.61
R-HSA-4086400	PCP/CE pathway	89	60	1.75	5.64	2.7e-08	2.5e-07	3.35	2.11	5.42
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	28	25	2.32	5.53	3.3e-08	3.1e-07	13.4	4.09	69.4
R-HSA-72649	Translation initiation complex formation	58	43	1.93	5.6	3.4e-08	3.2e-07	4.62	2.51	8.97
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	80	55	1.79	5.59	3.6e-08	3.2e-07	3.55	2.17	5.96
R-HSA-380287	Centrosome maturation	80	55	1.79	5.59	3.6e-08	3.2e-07	3.55	2.17	5.96
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	51	39	1.99	5.59	3.5e-08	3.2e-07	5.24	2.68	11
R-HSA-69239	Synthesis of DNA	99	65	1.71	5.59	3.5e-08	3.2e-07	3.09	2.01	4.84
R-HSA-9006925	Intracellular signaling by second messengers	282	153	1.41	5.53	3.7e-08	3.3e-07	1.93	1.51	2.47
R-HSA-69202	Cyclin E associated events during G1/S transition 	82	56	1.78	5.57	3.9e-08	3.4e-07	3.48	2.15	5.79
R-HSA-948021	Transport to the Golgi and subsequent modification	186	108	1.51	5.54	3.8e-08	3.4e-07	2.25	1.66	3.06
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	60	44	1.91	5.57	4.1e-08	3.6e-07	4.44	2.45	8.44
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	60	44	1.91	5.57	4.1e-08	3.6e-07	4.44	2.45	8.44
R-HSA-5610787	Hedgehog 'off' state	113	72	1.66	5.55	4.2e-08	3.6e-07	2.84	1.91	4.29
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	73	51	1.82	5.53	4.9e-08	4.2e-07	3.74	2.23	6.49
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	75	52	1.8	5.51	5.4e-08	4.6e-07	3.65	2.19	6.26
R-HSA-69563	p53-Dependent G1 DNA Damage Response	66	47	1.85	5.49	6.4e-08	5.4e-07	3.99	2.29	7.22
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	66	47	1.85	5.49	6.4e-08	5.4e-07	3.99	2.29	7.22
R-HSA-2871837	FCERI mediated NF-kB activation	79	54	1.78	5.48	6.5e-08	5.4e-07	3.49	2.13	5.86
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	200	114	1.48	5.44	6.5e-08	5.4e-07	2.15	1.61	2.89
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	81	55	1.77	5.47	7e-08	5.7e-07	3.42	2.1	5.69
R-HSA-69615	G1/S DNA Damage Checkpoints	68	48	1.83	5.46	7.3e-08	6e-07	3.87	2.25	6.9
R-HSA-5387390	Hh mutants abrogate ligand secretion	59	43	1.89	5.45	7.9e-08	6.4e-07	4.34	2.39	8.26
R-HSA-5687128	MAPK6/MAPK4 signaling	89	59	1.72	5.42	8.9e-08	7.2e-07	3.18	2.01	5.12
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	76	52	1.78	5.39	1.1e-07	8.6e-07	3.5	2.11	5.94
R-HSA-73776	RNA Polymerase II Promoter Escape	47	36	1.99	5.38	1.1e-07	8.6e-07	5.27	2.62	11.5
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	47	36	1.99	5.38	1.1e-07	8.6e-07	5.27	2.62	11.5
R-HSA-75953	RNA Polymerase II Transcription Initiation	47	36	1.99	5.38	1.1e-07	8.6e-07	5.27	2.62	11.5
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	47	36	1.99	5.38	1.1e-07	8.6e-07	5.27	2.62	11.5
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	80	54	1.75	5.36	1.3e-07	9.6e-07	3.35	2.06	5.59
R-HSA-8878166	Transcriptional regulation by RUNX2	80	54	1.75	5.36	1.3e-07	9.6e-07	3.35	2.06	5.59
R-HSA-72702	Ribosomal scanning and start codon recognition	58	42	1.88	5.33	1.5e-07	1.1e-06	4.23	2.33	8.08
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	86	57	1.72	5.32	1.5e-07	1.1e-06	3.18	1.99	5.16
R-HSA-453276	Regulation of mitotic cell cycle	86	57	1.72	5.32	1.5e-07	1.1e-06	3.18	1.99	5.16
R-HSA-5607764	CLEC7A (Dectin-1) signaling	96	62	1.68	5.28	1.8e-07	1.3e-06	2.95	1.91	4.63
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	126	77	1.59	5.26	1.9e-07	1.4e-06	2.54	1.75	3.73
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	108	68	1.64	5.26	2e-07	1.4e-06	2.75	1.83	4.18
R-HSA-69481	G2/M Checkpoints	167	97	1.51	5.25	1.8e-07	1.4e-06	2.25	1.63	3.11
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	93	60	1.68	5.19	3e-07	2.2e-06	2.94	1.89	4.65
R-HSA-77595	Processing of Intronless Pre-mRNAs	19	18	2.46	5.05	4e-07	2.9e-06	28.9	4.56	1200
R-HSA-113418	Formation of the Early Elongation Complex	33	27	2.13	5.13	4.2e-07	3e-06	7.24	2.92	21.5
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	84	55	1.7	5.11	4.5e-07	3.2e-06	3.06	1.92	4.99
R-HSA-162599	Late Phase of HIV Life Cycle	88	57	1.68	5.09	4.8e-07	3.4e-06	2.97	1.88	4.77
R-HSA-432722	Golgi Associated Vesicle Biogenesis	56	40	1.86	5.08	5.5e-07	3.8e-06	4.03	2.2	7.72
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	100	63	1.64	5.07	5.3e-07	3.8e-06	2.75	1.8	4.26
R-HSA-6807878	COPI-mediated anterograde transport	102	64	1.63	5.06	5.4e-07	3.8e-06	2.72	1.79	4.19
R-HSA-68949	Orc1 removal from chromatin	71	48	1.76	5.06	5.8e-07	4e-06	3.37	2	5.81
R-HSA-69052	Switching of origins to a post-replicative state	71	48	1.76	5.06	5.8e-07	4e-06	3.37	2	5.81
R-HSA-69300	Removal of licensing factors from origins	73	49	1.74	5.05	6.2e-07	4.3e-06	3.29	1.98	5.62
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	75	50	1.73	5.04	6.6e-07	4.5e-06	3.23	1.96	5.45
R-HSA-2262749	Cellular response to hypoxia	75	50	1.73	5.04	6.6e-07	4.5e-06	3.23	1.96	5.45
R-HSA-3858494	Beta-catenin independent WNT signaling	137	81	1.54	5	6.8e-07	4.6e-06	2.34	1.64	3.36
R-HSA-5619084	ABC transporter disorders	81	53	1.7	5.01	7.5e-07	5.1e-06	3.06	1.89	5.03
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	51	37	1.89	5.01	7.8e-07	5.2e-06	4.26	2.24	8.54
R-HSA-5358346	Hedgehog ligand biogenesis	64	44	1.79	4.99	8.4e-07	5.6e-06	3.55	2.04	6.36
R-HSA-5358351	Signaling by Hedgehog	148	86	1.51	4.95	8.7e-07	5.8e-06	2.25	1.6	3.17
R-HSA-162587	HIV Life Cycle	101	63	1.62	4.96	8.9e-07	5.9e-06	2.68	1.76	4.13
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	68	46	1.76	4.96	9.7e-07	6.4e-06	3.37	1.98	5.9
R-HSA-446652	Interleukin-1 family signaling	138	81	1.53	4.92	1e-06	6.7e-06	2.3	1.61	3.3
R-HSA-69304	Regulation of DNA replication	76	50	1.71	4.91	1.2e-06	7.8e-06	3.1	1.89	5.2
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	29	24	2.15	4.91	1.3e-06	8.1e-06	7.72	2.88	25.9
R-HSA-72086	mRNA Capping	29	24	2.15	4.91	1.3e-06	8.1e-06	7.72	2.88	25.9
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	78	51	1.7	4.9	1.3e-06	8.1e-06	3.05	1.87	5.06
R-HSA-9020702	Interleukin-1 signaling	102	63	1.61	4.86	1.5e-06	9.3e-06	2.61	1.72	4.01
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	50	36	1.87	4.89	1.5e-06	9.4e-06	4.14	2.18	8.32
R-HSA-5696395	Formation of Incision Complex in GG-NER	43	32	1.93	4.86	1.7e-06	1.1e-05	4.68	2.3	10.3
R-HSA-6803529	FGFR2 alternative splicing	26	22	2.2	4.84	1.7e-06	1.1e-05	8.84	3	35.3
R-HSA-68877	Mitotic Prometaphase	199	109	1.42	4.77	1.8e-06	1.1e-05	1.96	1.47	2.63
R-HSA-5632684	Hedgehog 'on' state	85	54	1.65	4.77	2.3e-06	1.5e-05	2.81	1.77	4.53
R-HSA-1632852	Macroautophagy	68	45	1.72	4.71	3.2e-06	2e-05	3.15	1.87	5.47
R-HSA-5633007	Regulation of TP53 Activity	160	90	1.46	4.66	3.3e-06	2e-05	2.08	1.5	2.89
R-HSA-199992	trans-Golgi Network Vesicle Budding	72	47	1.7	4.69	3.5e-06	2.1e-05	3.03	1.82	5.15
R-HSA-421837	Clathrin derived vesicle budding	72	47	1.7	4.69	3.5e-06	2.1e-05	3.03	1.82	5.15
R-HSA-1430728	Metabolism	1899	817	1.12	4.53	3.7e-06	2.2e-05	1.26	1.14	1.4
R-HSA-73772	RNA Polymerase I Promoter Escape	30	24	2.08	4.68	4e-06	2.4e-05	6.43	2.56	19.2
R-HSA-9007101	Rab regulation of trafficking	123	72	1.52	4.6	4.6e-06	2.8e-05	2.28	1.57	3.34
R-HSA-8943724	Regulation of PTEN gene transcription	61	41	1.75	4.63	4.9e-06	2.9e-05	3.3	1.89	5.96
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	27	22	2.12	4.6	5.9e-06	3.5e-05	7.07	2.61	23.9
R-HSA-5689603	UCH proteinases	97	59	1.58	4.55	6.3e-06	3.7e-05	2.51	1.64	3.88
R-HSA-5620924	Intraflagellar transport	54	37	1.78	4.55	7.1e-06	4.2e-05	3.5	1.92	6.65
R-HSA-382556	ABC-family proteins mediated transport	104	62	1.55	4.46	9.3e-06	5.4e-05	2.38	1.58	3.62
R-HSA-74160	Gene expression (Transcription)	1335	585	1.14	4.32	1e-05	5.9e-05	1.29	1.15	1.45
R-HSA-73863	RNA Polymerase I Transcription Termination	31	24	2.01	4.46	1.1e-05	6.6e-05	5.51	2.3	15.2
R-HSA-5673001	RAF/MAP kinase cascade	243	126	1.35	4.34	1.2e-05	7.2e-05	1.75	1.34	2.27
R-HSA-5683057	MAPK family signaling cascades	288	146	1.32	4.33	1.3e-05	7.3e-05	1.67	1.31	2.13
R-HSA-168325	Viral Messenger RNA Synthesis	42	30	1.86	4.4	1.5e-05	8.3e-05	4.02	2	8.64
R-HSA-1280218	Adaptive Immune System	746	341	1.19	4.22	1.7e-05	9.4e-05	1.38	1.18	1.61
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	65	42	1.68	4.35	1.7e-05	9.5e-05	2.94	1.73	5.13
R-HSA-166208	mTORC1-mediated signalling	23	19	2.15	4.36	1.9e-05	1e-04	7.63	2.53	30.9
R-HSA-167169	HIV Transcription Elongation	23	19	2.15	4.36	1.9e-05	1e-04	7.63	2.53	30.9
R-HSA-167172	Transcription of the HIV genome	23	19	2.15	4.36	1.9e-05	1e-04	7.63	2.53	30.9
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	23	19	2.15	4.36	1.9e-05	1e-04	7.63	2.53	30.9
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	23	19	2.15	4.36	1.9e-05	1e-04	7.63	2.53	30.9
R-HSA-4570464	SUMOylation of RNA binding proteins	46	32	1.81	4.34	1.8e-05	1e-04	3.68	1.9	7.47
R-HSA-8878159	Transcriptional regulation by RUNX3	108	63	1.52	4.27	2.1e-05	0.00011	2.26	1.51	3.4
R-HSA-429914	Deadenylation-dependent mRNA decay	55	36	1.7	4.12	4.4e-05	0.00024	3.05	1.7	5.64
R-HSA-381038	XBP1(S) activates chaperone genes	57	37	1.69	4.11	4.6e-05	0.00025	2.98	1.68	5.42
R-HSA-5684996	MAPK1/MAPK3 signaling	249	126	1.32	3.98	5.5e-05	0.00029	1.66	1.28	2.15
R-HSA-202424	Downstream TCR signaling	98	57	1.51	4.03	5.7e-05	3e-04	2.24	1.47	3.44
R-HSA-8856688	Golgi-to-ER retrograde transport	134	74	1.44	4.01	5.6e-05	3e-04	1.99	1.39	2.86
R-HSA-5688426	Deubiquitination	295	146	1.29	3.95	6.1e-05	0.00032	1.59	1.25	2.02
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	46	31	1.75	4.04	6.5e-05	0.00034	3.32	1.74	6.64
R-HSA-3371556	Cellular response to heat stress	88	52	1.54	3.99	6.7e-05	0.00035	2.33	1.49	3.67
R-HSA-191859	snRNP Assembly	52	34	1.7	4	7.4e-05	0.00039	3.04	1.67	5.72
R-HSA-194441	Metabolism of non-coding RNA	52	34	1.7	4	7.4e-05	0.00039	3.04	1.67	5.72
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	76	46	1.57	3.97	7.7e-05	4e-04	2.47	1.52	4.06
R-HSA-2990846	SUMOylation	127	70	1.43	3.88	9.5e-05	0.00049	1.98	1.37	2.87
R-HSA-195721	Signaling by WNT	314	153	1.27	3.8	0.00011	0.00057	1.54	1.22	1.94
R-HSA-8854214	TBC/RABGAPs	45	30	1.73	3.9	0.00012	0.00059	3.22	1.67	6.44
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	47	31	1.71	3.88	0.00012	0.00062	3.12	1.65	6.11
R-HSA-5654738	Signaling by FGFR2	73	44	1.57	3.84	0.00013	0.00064	2.44	1.49	4.06
R-HSA-5663220	RHO GTPases Activate Formins	141	76	1.4	3.79	0.00013	0.00066	1.89	1.33	2.68
R-HSA-381070	IRE1alpha activates chaperones	59	37	1.63	3.84	0.00013	0.00068	2.71	1.55	4.82
R-HSA-429947	Deadenylation of mRNA	25	19	1.98	3.86	0.00015	0.00076	5.08	1.95	15.6
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	90	52	1.5	3.78	0.00015	0.00076	2.2	1.42	3.45
R-HSA-201681	TCF dependent signaling in response to WNT	224	113	1.31	3.73	0.00015	0.00076	1.65	1.25	2.17
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	487	226	1.21	3.69	0.00015	0.00076	1.41	1.17	1.7
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	36	25	1.81	3.83	0.00016	0.00079	3.65	1.73	8.23
R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	38	26	1.78	3.8	0.00017	0.00085	3.48	1.69	7.58
R-HSA-1268020	Mitochondrial protein import	20	16	2.08	3.82	0.00018	9e-04	6.42	2.07	26.4
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	40	27	1.75	3.78	0.00018	0.00091	3.34	1.66	7.06
R-HSA-6802957	Oncogenic MAPK signaling	76	45	1.54	3.73	0.00019	0.00093	2.34	1.44	3.83
R-HSA-69618	Mitotic Spindle Checkpoint	112	62	1.44	3.69	2e-04	0.00096	2	1.35	2.97
R-HSA-6784531	tRNA processing in the nucleus	56	35	1.62	3.71	0.00022	0.0011	2.68	1.52	4.85
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	121	66	1.42	3.66	0.00022	0.0011	1.94	1.33	2.83
R-HSA-195258	RHO GTPase Effectors	313	151	1.25	3.61	0.00022	0.0011	1.51	1.2	1.9
R-HSA-5339562	Uptake and actions of bacterial toxins	31	22	1.84	3.72	0.00024	0.0012	3.93	1.74	9.7
R-HSA-194315	Signaling by Rho GTPases	441	205	1.21	3.54	0.00027	0.0013	1.41	1.16	1.72
R-HSA-203927	MicroRNA (miRNA) biogenesis	24	18	1.95	3.68	3e-04	0.0014	4.82	1.83	14.8
R-HSA-8852135	Protein ubiquitination	77	45	1.52	3.62	0.00029	0.0014	2.26	1.4	3.69
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	92	52	1.47	3.58	0.00032	0.0015	2.09	1.36	3.25
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	41	27	1.71	3.61	0.00034	0.0016	3.1	1.57	6.4
R-HSA-77387	Insulin receptor recycling	26	19	1.9	3.63	0.00036	0.0017	4.36	1.75	12.3
R-HSA-202403	TCR signaling	116	63	1.41	3.53	0.00036	0.0017	1.92	1.31	2.82
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	19	15	2.05	3.63	0.00039	0.0018	6.02	1.91	24.9
R-HSA-1643713	Signaling by EGFR in Cancer	19	15	2.05	3.63	0.00039	0.0018	6.02	1.91	24.9
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	19	15	2.05	3.63	0.00039	0.0018	6.02	1.91	24.9
R-HSA-351202	Metabolism of polyamines	84	48	1.49	3.53	0.00038	0.0018	2.15	1.36	3.41
R-HSA-901032	ER Quality Control Compartment (ERQC)	21	16	1.98	3.56	0.00049	0.0022	5.13	1.8	17.9
R-HSA-5689880	Ub-specific processing proteases	220	109	1.29	3.41	0.00047	0.0022	1.59	1.2	2.09
R-HSA-3247509	Chromatin modifying enzymes	227	112	1.28	3.4	0.00049	0.0022	1.57	1.2	2.07
R-HSA-4839726	Chromatin organization	227	112	1.28	3.4	0.00049	0.0022	1.57	1.2	2.07
R-HSA-170834	Signaling by TGF-beta Receptor Complex	66	39	1.54	3.45	0.00053	0.0024	2.32	1.38	3.95
R-HSA-190236	Signaling by FGFR	87	49	1.46	3.44	0.00053	0.0024	2.08	1.33	3.27
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	102	56	1.43	3.43	0.00052	0.0024	1.96	1.3	2.97
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	23	17	1.92	3.5	6e-04	0.0026	4.55	1.71	14.1
R-HSA-177929	Signaling by EGFR	40	26	1.69	3.46	6e-04	0.0026	2.98	1.5	6.19
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	56	34	1.58	3.43	6e-04	0.0026	2.48	1.41	4.47
R-HSA-917937	Iron uptake and transport	58	35	1.57	3.43	0.00059	0.0026	2.45	1.4	4.34
R-HSA-6811438	Intra-Golgi traffic	44	28	1.65	3.44	0.00062	0.0027	2.81	1.47	5.57
R-HSA-182971	EGFR downregulation	25	18	1.87	3.45	0.00069	0.003	4.13	1.64	11.7
R-HSA-5673000	RAF activation	25	18	1.87	3.45	0.00069	0.003	4.13	1.64	11.7
R-HSA-166520	Signalling by NGF	147	76	1.34	3.32	7e-04	0.003	1.73	1.23	2.43
R-HSA-1169408	ISG15 antiviral mechanism	71	41	1.5	3.35	0.00074	0.0032	2.2	1.34	3.65
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	71	41	1.5	3.35	0.00074	0.0032	2.2	1.34	3.65
R-HSA-4551638	SUMOylation of chromatin organization proteins	69	40	1.51	3.34	0.00077	0.0033	2.22	1.34	3.72
R-HSA-163210	Formation of ATP by chemiosmotic coupling	18	14	2.02	3.43	8e-04	0.0034	5.61	1.76	23.4
R-HSA-8949613	Cristae formation	18	14	2.02	3.43	8e-04	0.0034	5.61	1.76	23.4
R-HSA-917977	Transferrin endocytosis and recycling	31	21	1.76	3.35	9e-04	0.0038	3.37	1.52	8.03
R-HSA-381119	Unfolded Protein Response (UPR)	93	51	1.43	3.26	0.00095	0.004	1.95	1.27	3.02
R-HSA-432720	Lysosome Vesicle Biogenesis	35	23	1.71	3.32	0.00099	0.0041	3.08	1.47	6.8
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	35	23	1.71	3.32	0.00099	0.0041	3.08	1.47	6.8
R-HSA-5620920	Cargo trafficking to the periciliary membrane	51	31	1.58	3.28	0.001	0.0042	2.49	1.37	4.62
R-HSA-5696400	Dual Incision in GG-NER	41	26	1.65	3.29	0.001	0.0043	2.78	1.42	5.66
R-HSA-1236394	Signaling by ERBB4	43	27	1.63	3.28	0.001	0.0043	2.71	1.41	5.39
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	22	16	1.89	3.31	0.0012	0.0048	4.28	1.59	13.4
R-HSA-8878171	Transcriptional regulation by RUNX1	236	114	1.26	3.14	0.0012	0.0048	1.51	1.16	1.97
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	10	9	2.34	3.35	0.0012	0.0049	14.4	2	631
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	68	39	1.49	3.21	0.0012	0.0049	2.16	1.3	3.63
R-HSA-5621481	C-type lectin receptors (CLRs)	138	71	1.34	3.16	0.0012	0.005	1.71	1.2	2.43
R-HSA-5637810	Constitutive Signaling by EGFRvIII	15	12	2.08	3.31	0.0013	0.0052	6.41	1.73	35.4
R-HSA-5637812	Signaling by EGFRvIII in Cancer	15	12	2.08	3.31	0.0013	0.0052	6.41	1.73	35.4
R-HSA-73857	RNA Polymerase II Transcription	1230	522	1.1	3.05	0.0013	0.0053	1.21	1.07	1.36
R-HSA-6802952	Signaling by BRAF and RAF fusions	60	35	1.52	3.17	0.0014	0.0056	2.25	1.31	3.93
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	52	31	1.55	3.14	0.0016	0.0063	2.37	1.32	4.35
R-HSA-5655862	Translesion synthesis by POLK	17	13	1.99	3.22	0.0016	0.0065	5.21	1.61	22
R-HSA-5656121	Translesion synthesis by POLI	17	13	1.99	3.22	0.0016	0.0065	5.21	1.61	22
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	30	20	1.73	3.18	0.0016	0.0065	3.21	1.43	7.69
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	30	20	1.73	3.18	0.0016	0.0065	3.21	1.43	7.69
R-HSA-4791275	Signaling by WNT in cancer	34	22	1.68	3.15	0.0017	0.0068	2.94	1.39	6.53
R-HSA-74158	RNA Polymerase III Transcription	36	23	1.66	3.14	0.0017	0.0068	2.84	1.38	6.11
R-HSA-76046	RNA Polymerase III Transcription Initiation	36	23	1.66	3.14	0.0017	0.0068	2.84	1.38	6.11
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	42	26	1.61	3.13	0.0017	0.0068	2.61	1.35	5.21
R-HSA-5655302	Signaling by FGFR1 in disease	38	24	1.64	3.13	0.0018	0.0068	2.75	1.37	5.76
R-HSA-5675221	Negative regulation of MAPK pathway	40	25	1.62	3.13	0.0018	0.0068	2.68	1.36	5.47
R-HSA-71403	Citric acid cycle (TCA cycle)	19	14	1.92	3.16	0.002	0.0076	4.49	1.53	15.9
R-HSA-5693532	DNA Double-Strand Break Repair	165	82	1.29	2.99	0.002	0.0078	1.59	1.16	2.19
R-HSA-6807004	Negative regulation of MET activity	21	15	1.86	3.11	0.0022	0.0086	4.01	1.47	12.6
R-HSA-141424	Amplification of signal from the kinetochores	96	51	1.38	2.97	0.0024	0.0091	1.82	1.19	2.79
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	96	51	1.38	2.97	0.0024	0.0091	1.82	1.19	2.79
R-HSA-174490	Membrane binding and targetting of GAG proteins	14	11	2.04	3.09	0.0027	0.01	5.88	1.55	32.8
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	14	11	2.04	3.09	0.0027	0.01	5.88	1.55	32.8
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	14	11	2.04	3.09	0.0027	0.01	5.88	1.55	32.8
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	47	28	1.55	2.98	0.0027	0.01	2.37	1.27	4.49
R-HSA-2682334	EPH-Ephrin signaling	81	44	1.41	2.94	0.0026	0.01	1.91	1.2	3.05
R-HSA-70326	Glucose metabolism	81	44	1.41	2.94	0.0026	0.01	1.91	1.2	3.05
R-HSA-5205647	Mitophagy	29	19	1.7	3	0.0029	0.011	3.05	1.35	7.35
R-HSA-176033	Interactions of Vpr with host cellular proteins	35	22	1.63	2.97	0.003	0.011	2.72	1.31	5.88
R-HSA-177243	Interactions of Rev with host cellular proteins	35	22	1.63	2.97	0.003	0.011	2.72	1.31	5.88
R-HSA-6806003	Regulation of TP53 Expression and Degradation	37	23	1.62	2.97	0.0029	0.011	2.64	1.3	5.55
R-HSA-8953750	Transcriptional Regulation by E2F6	35	22	1.63	2.97	0.003	0.011	2.72	1.31	5.88
R-HSA-8873719	RAB geranylgeranylation	64	36	1.46	2.93	0.0029	0.011	2.07	1.22	3.52
R-HSA-110312	Translesion synthesis by REV1	16	12	1.95	3.01	0.0033	0.012	4.81	1.46	20.5
R-HSA-175474	Assembly Of The HIV Virion	16	12	1.95	3.01	0.0033	0.012	4.81	1.46	20.5
R-HSA-5619115	Disorders of transmembrane transporters	149	74	1.29	2.83	0.0033	0.012	1.59	1.13	2.23
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	18	13	1.88	2.95	0.0038	0.014	4.17	1.39	14.9
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	129	65	1.31	2.8	0.0037	0.014	1.63	1.14	2.35
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	127	64	1.31	2.78	0.0039	0.014	1.64	1.13	2.36
R-HSA-2028269	Signaling by Hippo	20	14	1.82	2.9	0.0042	0.015	3.74	1.35	11.9
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	11	9	2.13	2.96	0.0043	0.016	7.21	1.49	68.7
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	44	26	1.54	2.82	0.0044	0.016	2.32	1.22	4.5
R-HSA-70171	Glycolysis	61	34	1.45	2.78	0.0045	0.016	2.02	1.18	3.49
R-HSA-901042	Calnexin/calreticulin cycle	26	17	1.7	2.82	0.0049	0.017	3.03	1.28	7.72
R-HSA-5696394	DNA Damage Recognition in GG-NER	38	23	1.57	2.8	0.0048	0.017	2.46	1.23	5.08
R-HSA-6804757	Regulation of TP53 Degradation	36	22	1.59	2.8	0.0049	0.017	2.52	1.23	5.34
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	30	19	1.65	2.8	0.005	0.018	2.77	1.25	6.45
R-HSA-180910	Vpr-mediated nuclear import of PICs	32	20	1.62	2.8	0.005	0.018	2.67	1.24	6.01
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	57	32	1.46	2.75	0.005	0.018	2.06	1.18	3.62
R-HSA-6802949	Signaling by RAS mutants	53	30	1.47	2.72	0.0055	0.019	2.09	1.17	3.78
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	13	10	2	2.85	0.0056	0.02	5.34	1.37	30.2
R-HSA-5210891	Uptake and function of anthrax toxins	13	10	2	2.85	0.0056	0.02	5.34	1.37	30.2
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	51	29	1.48	2.71	0.0058	0.02	2.12	1.17	3.87
R-HSA-73854	RNA Polymerase I Promoter Clearance	106	54	1.32	2.65	0.0058	0.02	1.67	1.12	2.5
R-HSA-1227986	Signaling by ERBB2	49	28	1.49	2.69	0.006	0.021	2.14	1.17	3.97
R-HSA-73893	DNA Damage Bypass	49	28	1.49	2.69	0.006	0.021	2.14	1.17	3.97
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	75	40	1.39	2.66	0.0061	0.021	1.84	1.14	2.98
R-HSA-205043	NRIF signals cell death from the nucleus	15	11	1.91	2.78	0.0066	0.022	4.41	1.3	19
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	15	11	1.91	2.78	0.0066	0.022	4.41	1.3	19
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	15	11	1.91	2.78	0.0066	0.022	4.41	1.3	19
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	15	11	1.91	2.78	0.0066	0.022	4.41	1.3	19
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	15	11	1.91	2.78	0.0066	0.022	4.41	1.3	19
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	15	11	1.91	2.78	0.0066	0.022	4.41	1.3	19
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	15	11	1.91	2.78	0.0066	0.022	4.41	1.3	19
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	120	60	1.3	2.61	0.0064	0.022	1.61	1.1	2.35
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	60	33	1.43	2.64	0.0067	0.023	1.96	1.14	3.4
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	100	51	1.33	2.59	0.007	0.023	1.67	1.11	2.54
R-HSA-71291	Metabolism of amino acids and derivatives	251	116	1.2	2.55	0.0068	0.023	1.39	1.07	1.8
R-HSA-196299	Beta-catenin phosphorylation cascade	17	12	1.83	2.72	0.0073	0.024	3.85	1.26	14
R-HSA-168253	Host Interactions with Influenza Factors	41	24	1.52	2.65	0.0072	0.024	2.27	1.17	4.5
R-HSA-168276	NS1 Mediated Effects on Host Pathways	39	23	1.53	2.64	0.0074	0.025	2.31	1.17	4.68
R-HSA-8876725	Protein methylation	19	13	1.78	2.69	0.0079	0.026	3.47	1.23	11.2
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	21	14	1.73	2.66	0.0082	0.027	3.21	1.21	9.39
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	23	15	1.7	2.64	0.0084	0.027	3.01	1.2	8.2
R-HSA-191273	Cholesterol biosynthesis	25	16	1.66	2.63	0.0085	0.027	2.85	1.18	7.33
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	31	19	1.59	2.62	0.0083	0.027	2.54	1.17	5.74
R-HSA-159227	Transport of the SLBP independent Mature mRNA	33	20	1.58	2.62	0.0081	0.027	2.47	1.17	5.41
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	33	20	1.58	2.62	0.0081	0.027	2.47	1.17	5.41
R-HSA-1839124	FGFR1 mutant receptor activation	31	19	1.59	2.62	0.0083	0.027	2.54	1.17	5.74
R-HSA-2559585	Oncogene Induced Senescence	33	20	1.58	2.62	0.0081	0.027	2.47	1.17	5.41
R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	27	17	1.64	2.62	0.0085	0.027	2.73	1.18	6.67
R-HSA-373760	L1CAM interactions	76	40	1.37	2.55	0.0082	0.027	1.79	1.11	2.89
R-HSA-5693606	DNA Double Strand Break Response	76	40	1.37	2.55	0.0082	0.027	1.79	1.11	2.89
R-HSA-168799	Neurotoxicity of clostridium toxins	10	8	2.08	2.7	0.0093	0.03	6.41	1.28	62
R-HSA-3215018	Processing and activation of SUMO	10	8	2.08	2.7	0.0093	0.03	6.41	1.28	62
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	10	8	2.08	2.7	0.0093	0.03	6.41	1.28	62
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	10	8	2.08	2.7	0.0093	0.03	6.41	1.28	62
R-HSA-109581	Apoptosis	108	54	1.3	2.48	0.0094	0.03	1.61	1.08	2.39
R-HSA-73864	RNA Polymerase I Transcription	108	54	1.3	2.48	0.0094	0.03	1.61	1.08	2.39
R-HSA-5357801	Programmed Cell Death	115	57	1.29	2.46	0.0097	0.03	1.58	1.07	2.32
R-HSA-2559583	Cellular Senescence	194	91	1.22	2.44	0.0095	0.03	1.42	1.06	1.91
R-HSA-69231	Cyclin D associated events in G1	44	25	1.48	2.51	0.01	0.032	2.11	1.12	4.06
R-HSA-69236	G1 Phase	44	25	1.48	2.51	0.01	0.032	2.11	1.12	4.06
R-HSA-1236975	Antigen processing-Cross presentation	88	45	1.33	2.45	0.01	0.032	1.68	1.08	2.62
R-HSA-4420097	VEGFA-VEGFR2 Pathway	95	48	1.31	2.43	0.011	0.034	1.64	1.07	2.51
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	12	9	1.95	2.6	0.011	0.035	4.81	1.2	27.6
R-HSA-3371511	HSF1 activation	12	9	1.95	2.6	0.011	0.035	4.81	1.2	27.6
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	12	9	1.95	2.6	0.011	0.035	4.81	1.2	27.6
R-HSA-109606	Intrinsic Pathway for Apoptosis	40	23	1.49	2.48	0.011	0.035	2.17	1.11	4.33
R-HSA-6783310	Fanconi Anemia Pathway	40	23	1.49	2.48	0.011	0.035	2.17	1.11	4.33
R-HSA-111465	Apoptotic cleavage of cellular proteins	38	22	1.5	2.47	0.012	0.036	2.21	1.11	4.5
R-HSA-379726	Mitochondrial tRNA aminoacylation	14	10	1.86	2.54	0.013	0.038	4.01	1.15	17.5
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	14	10	1.86	2.54	0.013	0.038	4.01	1.15	17.5
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	14	10	1.86	2.54	0.013	0.038	4.01	1.15	17.5
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	14	10	1.86	2.54	0.013	0.038	4.01	1.15	17.5
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	14	10	1.86	2.54	0.013	0.038	4.01	1.15	17.5
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	14	10	1.86	2.54	0.013	0.038	4.01	1.15	17.5
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	14	10	1.86	2.54	0.013	0.038	4.01	1.15	17.5
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	34	20	1.53	2.44	0.013	0.038	2.29	1.1	4.91
R-HSA-75153	Apoptotic execution  phase	51	28	1.43	2.42	0.012	0.038	1.95	1.08	3.56
R-HSA-5693538	Homology Directed Repair	137	66	1.25	2.35	0.012	0.038	1.5	1.05	2.13
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	32	19	1.54	2.43	0.013	0.039	2.34	1.1	5.17
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	49	27	1.43	2.4	0.013	0.039	1.97	1.08	3.63
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	30	18	1.56	2.43	0.014	0.04	2.41	1.09	5.48
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	30	18	1.56	2.43	0.014	0.04	2.41	1.09	5.48
R-HSA-1295596	Spry regulation of FGF signaling	16	11	1.79	2.49	0.014	0.041	3.53	1.13	13
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	28	17	1.58	2.42	0.014	0.041	2.48	1.09	5.86
R-HSA-8964038	LDL clearance	18	12	1.73	2.46	0.014	0.042	3.21	1.11	10.4
R-HSA-9013507	NOTCH3 Activation and Transmission of Signal to the Nucleus	20	13	1.69	2.44	0.015	0.043	2.98	1.1	8.82
R-HSA-187687	Signalling to ERKs	22	14	1.65	2.43	0.015	0.043	2.81	1.1	7.73
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	22	14	1.65	2.43	0.015	0.043	2.81	1.1	7.73
R-HSA-69190	DNA strand elongation	24	15	1.62	2.42	0.015	0.043	2.67	1.09	6.93
R-HSA-69473	G2/M DNA damage checkpoint	94	47	1.3	2.31	0.015	0.043	1.61	1.05	2.47
R-HSA-1989781	PPARA activates gene expression	117	57	1.27	2.29	0.015	0.043	1.53	1.04	2.24
R-HSA-4615885	SUMOylation of DNA replication proteins	43	24	1.45	2.34	0.015	0.045	2.03	1.06	3.92
R-HSA-75893	TNF signaling	43	24	1.45	2.34	0.015	0.045	2.03	1.06	3.92
R-HSA-437239	Recycling pathway of L1	41	23	1.46	2.32	0.016	0.047	2.05	1.06	4.04
R-HSA-73884	Base Excision Repair	39	22	1.47	2.31	0.017	0.049	2.08	1.05	4.17
R-HSA-73933	Resolution of Abasic Sites (AP sites)	39	22	1.47	2.31	0.017	0.049	2.08	1.05	4.17
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	39	22	1.47	2.31	0.017	0.049	2.08	1.05	4.17
R-HSA-74752	Signaling by Insulin receptor	72	37	1.34	2.26	0.017	0.049	1.7	1.04	2.78
